Photo: Alamy
Health and Human Services Secretary Robert F. Kennedy Jr. may soon oversee a vote this week from federal vaccine advisors on the common use of the Hepatitis B vaccine for newborns.
According to a report from The Washington Post, a vaccine panel is set this week to vote on the practice of administering Hep B shots to newborns, according to comments that the newly-appointed chair, pediatric cardiologist Kirk Milhoan, gave the outlet.
The vote will likely take place on Thursday and will consider whether the Hep B vaccine should continue to be administered in the first 24 hours after birth or if there should be a “delay” interval before dosing.
According to the outlet, the panel will also soon begin “public discussions on its effort to review the childhood immunization schedule and the cumulative health effects of the dozens of shots children receive.”
This comes amid Secretary Kennedy’s bid to review vaccination recommendations and the underlying root causes of chronic diseases in America today.
This year, he announced the removal of the Covid vaccine from the CDC’s recommended immunization schedule for both healthy children and healthy pregnant women. “Last year, the Biden administration urged healthy children to get yet another Covid shot despite the lack of any clinical data to support the repeat booster strategy in children,” he said at the time.
The vaccine panel reviewing the effectiveness of the Hep B shot for infants comes shortly after Kennedy dismissed all 17 members of the panel this summer in a bid to restore trust in the CDC, which included removing “last minute” Biden appointees who had found disfavor with the American public.
“The public must know that unbiased science guides the recommendations from our health agencies,” Kennedy said, per RSBN. “This will ensure the American people receive the safest vaccines possible.”